Late effects of allogeneic bone marrow transplantation in children

C Bender-Götze1

  • 1Kinderpoliklinik der Universität, München, FRG.

Pediatrician
|January 1, 1991
PubMed

Insights

Bone marrow transplantation (BMT) survivors face numerous late sequelae, including growth issues, organ damage, and secondary cancers. Lifelong monitoring is crucial for early detection and management of these long-term effects.

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Background:

  • Bone marrow transplantation (BMT) is a life-saving procedure for various hematologic and oncologic conditions.
  • While BMT offers significant benefits, long-term survivors are susceptible to a range of adverse health issues known as late sequelae.
  • Identifying and managing these late effects is critical for improving the quality of life for BMT survivors.

Purpose of the Study:

  • To comprehensively review the spectrum of late sequelae following bone marrow transplantation.
  • To emphasize the necessity of lifelong surveillance for early detection and intervention of post-BMT complications.

Main Methods:

  • This review synthesizes existing literature on the late effects of bone marrow transplantation.
  • Key complications and their management strategies are discussed based on current evidence.

Main Results:

  • Late sequelae encompass diverse complications including growth impairment, gonadal failure, and organ-specific toxicities (neurological, pulmonary, renal, hepatic).
  • Increased risk of secondary malignancies and chronic graft-vs.-host disease are significant long-term concerns.
  • Psychosocial challenges also represent a substantial burden for survivors.

Conclusions:

  • Bone marrow transplantation can lead to a wide array of late sequelae affecting multiple organ systems and overall well-being.
  • Lifelong follow-up care is essential for BMT survivors to proactively identify and manage these potential long-term complications.
  • Effective management strategies and ongoing research are vital to mitigate the impact of late sequelae and enhance long-term outcomes for transplant recipients.

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...